New York 2025-2026 Regular Session

New York Assembly Bill A06475

Introduced

3/5/25

Refer

3/5/25

Caption

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

Latest NY A06475 Activity

View All Events: NY 2025-2026 Regular Session A06475

Companion Bills

No companion bills found.

Previously Filed As

NY S00927

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

NY A00738

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

NY A09075

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

NY S01187

Requires health insurance policies to offer full coverage for annual testing for ovarian cancer; requires certain health care providers offer annual testing for ovarian cancer.

NY A01641

Requires health insurance policies to offer full coverage for annual testing for ovarian cancer; requires certain health care providers offer annual testing for ovarian cancer.

NY S05134

Requires health insurance policies to fully cover multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.

NY A06186

Requires health insurance policies to fully cover multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.

NY A06089

Requires health insurance policies which provide coverage for mammography screenings also provide coverage for breast ultrasounds for cancer screening.

NY S07303

Requires insurance coverage for medical genetic testing for adoptees and persons placed in foster care.

NY S01193

Ensures ovarian cancer survivors have the right to access screenings for health conditions.

Similar Bills

No similar bills found.